{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:03:47Z","timestamp":1791972227119,"version":"4.3.4"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,6,6]],"date-time":"2020-06-06T00:00:00Z","timestamp":1591401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,6]],"date-time":"2020-06-06T00:00:00Z","timestamp":1591401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","award":["R01DE025822"],"award-info":[{"award-number":["R01DE025822"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30-CA051008"],"award-info":[{"award-number":["P30-CA051008"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Surviv"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s11764-020-00897-5","type":"journal-article","created":{"date-parts":[[2020,6,6]],"date-time":"2020-06-06T12:02:25Z","timestamp":1591444945000},"page":"847-857","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Looking under the hood of \u201cthe Cadillac of cancers:\u201d radioactive iodine-related craniofacial side effects among patients with thyroid cancer"],"prefix":"10.1007","volume":"14","author":[{"given":"Samantha A.","family":"Diamond-Rossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Jonklaas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxanne E.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlene","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selma","family":"Stearns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce J.","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Luta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Bloom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8808-1631","authenticated-orcid":false,"given":"Kristi D.","family":"Graves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,6]]},"reference":[{"issue":"13","key":"897_CR1","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1001\/jama.2017.2719","volume":"317","author":"H Lim","year":"2017","unstructured":"Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM. Trends in thyroid cancer incidence and mortality in the United States, 1974-2013. JAMA. 2017;317(13):1338\u201348.","journal-title":"JAMA."},{"issue":"3","key":"897_CR2","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S0360-3016(01)02686-4","volume":"52","author":"SM Chow","year":"2002","unstructured":"Chow SM, Law SC, Mendenhall WM, Au SK, Chan PT, Leung TW, et al. Papillary thyroid carcinoma: prognostic factors and the role of radioiodine and external radiotherapy. Int J Radiat Oncol Biol Phys. 2002;52(3):784\u201395.","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"4","key":"897_CR3","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1677\/erc.1.01320","volume":"13","author":"SM Chow","year":"2006","unstructured":"Chow SM, Yau S, Kwan CK, Poon PC, Law SC. Local and regional control in patients with papillary thyroid carcinoma: specific indications of external radiotherapy and radioactive iodine according to T and N categories in AJCC 6th edition. Endocr Relat Cancer. 2006;13(4):1159\u201372.","journal-title":"Endocr Relat Cancer."},{"issue":"12","key":"897_CR4","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.6004\/jnccn.2014.0169","volume":"12","author":"RM Tuttle","year":"2014","unstructured":"Tuttle RM, Haddad RI, Ball DW, Byrd D, Dickson P, Duh QY, et al. Thyroid carcinoma, version 2.2014. J Natl Compr Canc Netw. 2014;12(12):1671\u201380 quiz 80.","journal-title":"J Natl Compr Canc Netw."},{"issue":"1","key":"897_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26(1):1\u2013133.","journal-title":"Thyroid."},{"issue":"12","key":"897_CR6","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1089\/thy.2006.16.1229","volume":"16","author":"J Jonklaas","year":"2006","unstructured":"Jonklaas J, Sarlis NJ, Litofsky D, Ain KB, Bigos ST, Brierley JD, et al. Outcomes of patients with differentiated thyroid carcinoma following initial therapy. Thyroid. 2006;16(12):1229\u201342.","journal-title":"Thyroid."},{"issue":"1","key":"897_CR7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1089\/thy.2017.0129","volume":"29","author":"M Luster","year":"2019","unstructured":"Luster M, Aktolun C, Amendoeira I, Barczynski M, Bible KC, Duntas LH, et al. European Perspective on 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: Proceedings of an Interactive International Symposium. Thyroid. 2019;29(1):7\u201326.","journal-title":"Thyroid."},{"issue":"4","key":"897_CR8","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1089\/thy.2010.0403","volume":"21","author":"JC Sisson","year":"2011","unstructured":"American Thyroid Association Taskforce On Radioiodine S, Sisson JC, Freitas J, McDougall IR, Dauer LT, Hurley JR, et al. Radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I : practice recommendations of the American Thyroid Association. Thyroid. 2011;21(4):335\u201346.","journal-title":"Thyroid."},{"issue":"6","key":"897_CR9","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1089\/thy.2012.0307","volume":"23","author":"IJ Nixon","year":"2013","unstructured":"Nixon IJ, Ganly I, Patel SG, Palmer FL, Di Lorenzo MM, Grewal RK, et al. The results of selective use of radioactive iodine on survival and on recurrence in the management of papillary thyroid cancer, based on Memorial Sloan-Kettering Cancer Center risk group stratification. Thyroid. 2013;23(6):683\u201394.","journal-title":"Thyroid."},{"issue":"4","key":"897_CR10","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1089\/thy.2014.0298","volume":"25","author":"W Sacks","year":"2015","unstructured":"Sacks W, Wong RM, Bresee C, Braunstein GD. Use of evidence-based guidelines reduces radioactive iodine treatment in patients with low-risk differentiated thyroid cancer. Thyroid. 2015;25(4):377\u201385.","journal-title":"Thyroid."},{"issue":"3","key":"897_CR11","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1210\/jc.2017-02269","volume":"103","author":"KW Park","year":"2018","unstructured":"Park KW, Wu JX, Du L, Leung AM, Yeh MW, Livhits MJ. Decreasing use of radioactive iodine for low-risk thyroid cancer in California, 1999 to 2015. J Clin Endocrinol Metab. 2018;103(3):1095\u2013101.","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"897_CR12","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1089\/105072504322880373","volume":"14","author":"A Mendoza","year":"2004","unstructured":"Mendoza A, Shaffer B, Karakla D, Mason ME, Elkins D, Goffman TE. Quality of life with well-differentiated thyroid cancer: treatment toxicities and their reduction. Thyroid. 2004;14(2):133\u201340.","journal-title":"Thyroid."},{"issue":"10","key":"897_CR13","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/00003072-199610000-00006","volume":"21","author":"WY Lin","year":"1996","unstructured":"Lin WY, Shen YY, Wang SJ. Short-term hazards of low-dose radioiodine ablation therapy in postsurgical thyroid cancer patients. Clin Nucl Med. 1996;21(10):780\u20132.","journal-title":"Clin Nucl Med."},{"issue":"11","key":"897_CR14","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/00003072-200211000-00003","volume":"27","author":"M Caglar","year":"2002","unstructured":"Caglar M, Tuncel M, Alpar R. Scintigraphic evaluation of salivary gland dysfunction in patients with thyroid cancer after radioiodine treatment. Clin Nucl Med. 2002;27(11):767\u201371.","journal-title":"Clin Nucl Med."},{"issue":"5","key":"897_CR15","first-page":"738","volume":"42","author":"R Solans","year":"2001","unstructured":"Solans R, Bosch JA, Galofre P, Porta F, Rosello J, Selva-O'Callagan A, et al. Salivary and lacrimal gland dysfunction (sicca syndrome) after radioiodine therapy. J Nucl Med. 2001;42(5):738\u201343.","journal-title":"J Nucl Med."},{"issue":"3","key":"897_CR16","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0360-3016(96)80016-2","volume":"35","author":"BL Malpani","year":"1996","unstructured":"Malpani BL, Samuel AM, Ray S. Quantification of salivary gland function in thyroid cancer patients treated with radioiodine. Int J Radiat Oncol Biol Phys. 1996;35(3):535\u201340.","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"10","key":"897_CR17","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s002590000333","volume":"27","author":"S Hoelzer","year":"2000","unstructured":"Hoelzer S, Steiner D, Bauer R, Reiners C, Farahati J, Hundahl SA, et al. Current practice of radioiodine treatment in the management of differentiated thyroid cancer in Germany. Eur J Nucl Med. 2000;27(10):1465\u201372.","journal-title":"Eur J Nucl Med."},{"issue":"2","key":"897_CR18","first-page":"261","volume":"46","author":"K Nakada","year":"2005","unstructured":"Nakada K, Ishibashi T, Takei T, Hirata K, Shinohara K, Katoh S, et al. Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer? J Nucl Med. 2005;46(2):261\u20136.","journal-title":"J Nucl Med."},{"issue":"7","key":"897_CR19","first-page":"755","volume":"25","author":"P Allweiss","year":"1984","unstructured":"Allweiss P, Braunstein GD, Katz A, Waxman A. Sialadenitis following I-131 therapy for thyroid carcinoma: concise communication. J Nucl Med. 1984;25(7):755\u20138.","journal-title":"J Nucl Med."},{"issue":"10","key":"897_CR20","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.2967\/jnumed.108.061382","volume":"50","author":"RK Grewal","year":"2009","unstructured":"Grewal RK, Larson SM, Pentlow CE, Pentlow KS, Gonen M, Qualey R, et al. Salivary gland side effects commonly develop several weeks after initial radioactive iodine ablation. J Nucl Med. 2009;50(10):1605\u201310.","journal-title":"J Nucl Med."},{"key":"897_CR21","first-page":"127","volume":"8","author":"SM Chow","year":"2005","unstructured":"Chow SM. Side effects of high-dose radioactive iodine for ablation or treatment of differentiated thyroid carcinoma. J HK Coll Radiol. 2005;8:127\u201335.","journal-title":"J HK Coll Radiol."},{"issue":"12","key":"897_CR22","doi-asserted-by":"crossref","first-page":"5817","DOI":"10.1210\/jc.2002-020210","volume":"87","author":"RT Kloos","year":"2002","unstructured":"Kloos RT, Duvuuri V, Jhiang SM, Cahill KV, Foster JA, Burns JA. Nasolacrimal drainage system obstruction from radioactive iodine therapy for thyroid carcinoma. J Clin Endocrinol Metab. 2002;87(12):5817\u201320.","journal-title":"J Clin Endocrinol Metab."},{"issue":"11","key":"897_CR23","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1007\/s00259-002-0969-0","volume":"29","author":"G Zettinig","year":"2002","unstructured":"Zettinig G, Hanselmayer G, Fueger BJ, Hofmann A, Pirich C, Nepp J, et al. Long-term impairment of the lacrimal glands after radioiodine therapy: a cross-sectional study. Eur J Nucl Med Mol Imaging. 2002;29(11):1428\u201332.","journal-title":"Eur J Nucl Med Mol Imaging."},{"issue":"10","key":"897_CR24","first-page":"1519","volume":"27","author":"D Van Nostrand","year":"1986","unstructured":"Van Nostrand D, Neutze J, Atkins F. Side effects of \"rational dose\" iodine-131 therapy for metastatic well-differentiated thyroid carcinoma. J Nucl Med. 1986;27(10):1519\u201327.","journal-title":"J Nucl Med."},{"issue":"12","key":"897_CR25","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1089\/thy.2014.0162","volume":"24","author":"J Jonklaas","year":"2014","unstructured":"Jonklaas J. Nasal symptoms after radioiodine therapy: a rarely described side effect with similar frequency to lacrimal dysfunction. Thyroid. 2014;24(12):1806\u201314.","journal-title":"Thyroid."},{"key":"897_CR26","doi-asserted-by":"crossref","unstructured":"Goswami S, Peipert BJ, Mongelli MN, Kurumety SK, Helenowski IB, Yount SE, et al. Clinical factors associated with worse quality-of-life scores in United States thyroid cancer survivors. Surgery. 2019.","DOI":"10.1016\/j.surg.2019.01.034"},{"issue":"10","key":"897_CR27","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1002\/hed.25325","volume":"40","author":"F Mols","year":"2018","unstructured":"Mols F, Schoormans D, Smit JWA, Netea-Maier RT, Links TP, van der Graaf WTA, et al. Age-related differences in health-related quality of life among thyroid cancer survivors compared with a normative sample: Results from the PROFILES Registry. Head Neck. 2018;40(10):2235\u201345.","journal-title":"Head Neck."},{"issue":"8","key":"897_CR28","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1089\/thy.2017.0213","volume":"28","author":"T Wang","year":"2018","unstructured":"Wang T, Jiang M, Ren Y, Liu Q, Zhao G, Cao C, et al. Health-related quality of life of community thyroid cancer survivors in Hangzhou, China. Thyroid. 2018;28(8):1013\u201323.","journal-title":"Thyroid."},{"issue":"4","key":"897_CR29","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/leu.2017.323","volume":"32","author":"RJ Molenaar","year":"2018","unstructured":"Molenaar RJ, Pleyer C, Radivoyevitch T, Sidana S, Godley A, Advani AS, et al. Risk of developing chronic myeloid neoplasms in well-differentiated thyroid cancer patients treated with radioactive iodine. Leukemia. 2018;32(4):952\u20139.","journal-title":"Leukemia."},{"issue":"2","key":"897_CR30","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ecl.2014.02.007","volume":"43","author":"AM Sawka","year":"2014","unstructured":"Sawka AM, Naeem A, Jones J, Lowe J, Segal P, Goguen J, et al. Persistent posttreatment fatigue in thyroid cancer survivors: a scoping review. Endocrinol Metab Clin North Am. 2014;43(2):475\u201394.","journal-title":"Endocrinol Metab Clin North Am."},{"issue":"7","key":"897_CR31","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.bjoms.2016.09.001","volume":"55","author":"SN Rogers","year":"2017","unstructured":"Rogers SN, Mepani V, Jackson S, Lowe D. Health-related quality of life, fear of recurrence, and emotional distress in patients treated for thyroid cancer. Br J Oral Maxillofac Surg. 2017;55(7):666\u201373.","journal-title":"Br J Oral Maxillofac Surg."},{"key":"897_CR32","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/1477-7525-8-101","volume":"8","author":"JI Lee","year":"2010","unstructured":"Lee JI, Kim SH, Tan AH, Kim HK, Jang HW, Hur KY, et al. Decreased health-related quality of life in disease-free survivors of differentiated thyroid cancer in Korea. Health Qual Life Outcomes. 2010;8:101.","journal-title":"Health Qual Life Outcomes."},{"issue":"6","key":"897_CR33","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.oraloncology.2015.03.008","volume":"51","author":"H Duan","year":"2015","unstructured":"Duan H, Gamper E, Becherer A, Hoffmann M. Quality of life aspects in the management of thyroid cancer. Oral Oncol. 2015;51(6):S1\u20135.","journal-title":"Oral Oncol."},{"issue":"1","key":"897_CR34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004191","volume":"4","author":"AM Sawka","year":"2009","unstructured":"Sawka AM, Goldstein DP, Brierley JD, Tsang RW, Rotstein L, Ezzat S, et al. The impact of thyroid cancer and post-surgical radioactive iodine treatment on the lives of thyroid cancer survivors: a qualitative study. PLoS One. 2009;4(1):e4191.","journal-title":"PLoS One."},{"issue":"1","key":"897_CR35","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.surg.2017.09.009","volume":"163","author":"B Aschebrook-Kilfoy","year":"2018","unstructured":"Aschebrook-Kilfoy B, Ferguson BA, Angelos P, Kaplan EL, Grogan RH, Gibbons RD. development of the ThyCAT: a clinically useful computerized adaptive test to assess quality of life in thyroid cancer survivors. Surgery. 2018;163(1):137\u201342.","journal-title":"Surgery."},{"key":"897_CR36","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jss.2017.11.069","volume":"226","author":"BC James","year":"2018","unstructured":"James BC, Aschebrook-Kilfoy B, White MG, Applewhite MK, Kaplan SP, Angelos P, et al. Quality of life in thyroid cancer-assessment of physician perceptions. J Surg Res. 2018;226:94\u20139.","journal-title":"J Surg Res."},{"issue":"6","key":"897_CR37","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1188\/13.ONF.596-600","volume":"40","author":"J Easley","year":"2013","unstructured":"Easley J, Miedema B, Robinson L. It's the \"good\" cancer, so who cares? Perceived lack of support among young thyroid cancer survivors. Oncol Nurs Forum. 2013;40(6):596\u2013600.","journal-title":"Oncol Nurs Forum."},{"issue":"7","key":"897_CR38","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1089\/thy.2016.0632","volume":"27","author":"RW Randle","year":"2017","unstructured":"Randle RW, Bushman NM, Orne J, Balentine CJ, Wendt E, Saucke M, et al. Papillary Thyroid cancer: the good and bad of the \"good cancer\". Thyroid. 2017;27(7):902\u20137.","journal-title":"Thyroid."},{"issue":"3","key":"897_CR39","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s11764-014-0345-7","volume":"8","author":"M Goldfarb","year":"2014","unstructured":"Goldfarb M, Casillas J. Unmet information and support needs in newly diagnosed thyroid cancer: comparison of adolescents\/young adults (AYA) and older patients. J Cancer Surviv. 2014;8(3):394\u2013401.","journal-title":"J Cancer Surviv."},{"key":"897_CR40","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3:77\u2013101. https:\/\/doi.org\/10.1191\/1478088706qp063oa.","journal-title":"Qual Res Psychol."},{"issue":"3","key":"897_CR41","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/1098-240X(200006)23:3<246::AID-NUR9>3.0.CO;2-H","volume":"23","author":"M Sandelowski","year":"2000","unstructured":"Sandelowski M. Combining qualitative and quantitative sampling, data collection, and analysis techniques in mixed-method studies. Res Nurs Health. 2000;23(3):246\u201355.","journal-title":"Res Nurs Health."},{"key":"897_CR42","volume-title":"Qualitative Data Analysis","author":"MB Miles","year":"1994","unstructured":"Miles MB, Huberman M. Qualitative Data Analysis. Thousand Oaks: SAGE Publications; 1994."},{"issue":"6","key":"897_CR43","doi-asserted-by":"crossref","first-page":"693","DOI":"10.5021\/ad.2014.26.6.693","volume":"26","author":"Y Choi","year":"2014","unstructured":"Choi Y, Lee JH, Kim YH, Lee YS, Chang HS, Park CS, et al. Impact of postthyroidectomy scar on the quality of life of thyroid cancer patients. Ann Dermatol. 2014;26(6):693\u20139.","journal-title":"Ann Dermatol."},{"issue":"3","key":"897_CR44","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000354803","volume":"2","author":"B Nygaard","year":"2013","unstructured":"Nygaard B, Bastholt L, Bennedbaek FN, Klausen TW, Bentzen J. A placebo-controlled, blinded and randomised study on the effects of recombinant human thyrotropin on quality of life in the treatment of thyroid cancer. Eur Thyroid J. 2013;2(3):195\u2013202.","journal-title":"Eur Thyroid J."},{"issue":"2","key":"897_CR45","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s11764-019-00745-1","volume":"13","author":"O Saeed","year":"2019","unstructured":"Saeed O, Bernstein LJ, Fazelzad R, Samuels M, Burmeister LA, Thabane L, et al. Cognitive functioning in thyroid cancer survivors: a systematic review and meta-analysis. J Cancer Surviv. 2019;13(2):231\u201343.","journal-title":"J Cancer Surviv."},{"issue":"6","key":"897_CR46","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1089\/thy.2015.0032","volume":"25","author":"S Morley","year":"2015","unstructured":"Morley S, Goldfarb M. Support needs and survivorship concerns of thyroid cancer patients. Thyroid. 2015;25(6):649\u201356.","journal-title":"Thyroid."},{"issue":"4","key":"897_CR47","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1365-2265.2010.03966.x","volume":"74","author":"AM Sawka","year":"2011","unstructured":"Sawka AM, Straus S, Gafni A, Brierley JD, Tsang RW, Rotstein L, et al. How can we meet the information needs of patients with early stage papillary thyroid cancer considering radioactive iodine remnant ablation? Clin Endocrinol (Oxf). 2011;74(4):419\u201323.","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"9","key":"897_CR48","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1089\/thy.2016.0039","volume":"26","author":"YG Hyun","year":"2016","unstructured":"Hyun YG, Alhashemi A, Fazelzad R, Goldberg AS, Goldstein DP, Sawka AM. A Systematic Review of Unmet Information and Psychosocial Support Needs of Adults Diagnosed with Thyroid Cancer. Thyroid. 2016;26(9):1239\u201350.","journal-title":"Thyroid."},{"issue":"8","key":"897_CR49","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/pon.3514","volume":"23","author":"O Husson","year":"2014","unstructured":"Husson O, Mols F, Oranje WA, Haak HR, Nieuwlaat WA, Netea-Maier RT, et al. Unmet information needs and impact of cancer in (long-term) thyroid cancer survivors: results of the PROFILES registry. Psychooncology. 2014;23(8):946\u201352.","journal-title":"Psychooncology."},{"key":"897_CR50","doi-asserted-by":"crossref","unstructured":"Wallner LP, Reyes-Gastelum D, Hamilton AS, Ward KC, Hawley ST, Haymart MR. Patient-Perceived Lack of Choice in Receipt of Radioactive Iodine for Treatment of Differentiated Thyroid Cancer. J Clin Oncol. 2019:JCO1802228.","DOI":"10.1200\/JCO.18.02228"},{"issue":"5","key":"897_CR51","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1007\/s11764-018-0707-7","volume":"12","author":"BE Blackburn","year":"2018","unstructured":"Blackburn BE, Ganz PA, Rowe K, Snyder J, Wan Y, Deshmukh V, et al. Reproductive and gynecological complication risks among thyroid cancer survivors. J Cancer Surviv. 2018;12(5):702\u201311.","journal-title":"J Cancer Surviv."},{"issue":"4","key":"897_CR52","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1089\/thy.2017.0442","volume":"28","author":"I Yaish","year":"2018","unstructured":"Yaish I, Azem F, Gutfeld O, Silman Z, Serebro M, Sharon O, et al. A single radioactive iodine treatment has a deleterious effect on ovarian reserve in women with thyroid cancer: results of a prospective pilot study. Thyroid. 2018;28(4):522\u20137.","journal-title":"Thyroid."},{"key":"897_CR53","doi-asserted-by":"crossref","unstructured":"Bourcigaux N, Rubino C, Berthaud I, Toubert ME, Donadille B, Leenhardt L, et al. Impact on testicular function of a single ablative activity of 3.7 GBq radioactive iodine for differentiated thyroid carcinoma. Hum Reprod. 2018.","DOI":"10.1093\/humrep\/dey222"},{"issue":"7","key":"897_CR54","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1001\/jamaoto.2016.4749","volume":"143","author":"L Davies","year":"2017","unstructured":"Davies L, Hendrickson CD, Hanson GS. Experience of US Patients who self-identify as having an overdiagnosed thyroid cancer: a qualitative analysis. JAMA Otolaryngol Head Neck Surg. 2017;143(7):663\u20139.","journal-title":"JAMA Otolaryngol Head Neck Surg."},{"issue":"5","key":"897_CR55","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1089\/thy.2012.0106","volume":"23","author":"SY Jeong","year":"2013","unstructured":"Jeong SY, Kim HW, Lee SW, Ahn BC, Lee J. Salivary gland function 5 years after radioactive iodine ablation in patients with differentiated thyroid cancer: direct comparison of pre- and postablation scintigraphies and their relation to xerostomia symptoms. Thyroid. 2013;23(5):609\u201316.","journal-title":"Thyroid."},{"key":"897_CR56","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3389\/fendo.2015.00100","volume":"6","author":"J Jonklaas","year":"2015","unstructured":"Jonklaas J, Wang H, Esposito G. Salivary function after radioiodine therapy: poor correlation between symptoms and salivary scintigraphy. Front Endocrinol (Lausanne). 2015;6:100.","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Journal of Cancer Survivorship"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-020-00897-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11764-020-00897-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-020-00897-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,5]],"date-time":"2021-06-05T23:55:50Z","timestamp":1622937350000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11764-020-00897-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,6]]},"references-count":56,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["897"],"URL":"https:\/\/doi.org\/10.1007\/s11764-020-00897-5","relation":{},"ISSN":["1932-2259","1932-2267"],"issn-type":[{"value":"1932-2259","type":"print"},{"value":"1932-2267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,6]]},"assertion":[{"value":"13 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Samantha A. Diamond declares that she has no conflict of interest. Jacqueline Jonklaas declares that she has no conflict of interest. Roxanne E. Jensen declares that she has no conflict of interest. Charlene Kuo declares that she has no conflict of interest. Selma Stearns declares that she has no conflict of interest. Giuseppe Esposito declares that he has no conflict of interest. Bruce J.\u00a0Davidson declares that he has no conflict of interest. George Luta declares that he has no conflict of interest. Gary Bloom declares that he is the co-founder and executive director of ThyCa. Kristi D. Graves declares that she has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}